Evidence map›Paper›PMID 28608226›Full record

ArticleMolecular and cellular biochemistry2017

Blocking RhoA/ROCK inhibits the pathogenesis of pemphigus vulgaris by suppressing oxidative stress and apoptosis through TAK1/NOD2-mediated NF-κB pathway.

Junqin Liang, Xuewen Zeng, Yilinuer Halifu, Wenjing Chen, Fengxia Hu, Peng Wang, Huan Zhang, Xiaojing Kang

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Vasodilator-Stimulated Phosphoprotein: Regulators of Adipokines Resistin and Phenotype Conversion of Epicardial Adipocytes.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  12. Analysis of circRNA-miRNA-mRNA Regulatory Network in Peripheral Blood of Radiation Workers.Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Junqin LiangDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, NO. 91 Tianchi Road, Urumchi, 830001, Xinjiang Uygur Autonomous Region, People's Republic of China.
Xuewen ZengDepartment of Plastic Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumchi, 830001, Xinjiang Uygur Autonomous Region, People's Republic of China.
Yilinuer HalifuDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, NO. 91 Tianchi Road, Urumchi, 830001, Xinjiang Uygur Autonomous Region, People's Republic of China.
Wenjing ChenDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, NO. 91 Tianchi Road, Urumchi, 830001, Xinjiang Uygur Autonomous Region, People's Republic of China.
Fengxia HuDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, NO. 91 Tianchi Road, Urumchi, 830001, Xinjiang Uygur Autonomous Region, People's Republic of China.
Peng WangDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, NO. 91 Tianchi Road, Urumchi, 830001, Xinjiang Uygur Autonomous Region, People's Republic of China.
Huan ZhangDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, NO. 91 Tianchi Road, Urumchi, 830001, Xinjiang Uygur Autonomous Region, People's Republic of China.
Xiaojing KangDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, NO. 91 Tianchi Road, Urumchi, 830001, Xinjiang Uygur Autonomous Region, People's Republic of China. xiaojingkangedu@163.com.
People's Hospital of Xinjiang Uygur Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress and apoptosis play critical roles in pemphigus vulgaris (PV). The main aim of the present study was to investigate the effects of RhoA/ROCK signaling on UVB-induced oxidative damage, and to delineate the molecular mechanisms involved in the UVB-mediated inflammatory and apoptotic response. In HaCaT cells, we observed that blockage of RhoA/ROCK signaling with the inhibitor CT04 or Y27632 greatly inhibited the UVB-mediated increase in intracellular reactive oxygen species (ROS). Additionally, inhibition of RhoA/ROCK signaling reduced UVB-induced apoptosis, as exemplified by a reduction in DNA fragmentation, and also elevated anti-apoptotic Bcl-2 protein, concomitant with reduced levels of pro-apoptotic protein Bax, caspase-3 cleavage and decreased PARP-1 protein. The release of inflammatory mediators TNF-α, IL-1β, and IL-6 was also attenuated. Mechanically, we observed that blockage of RhoA/ROCK repressed the TAK1/NOD2-mediated NF-κB pathway in HaCaT cells exposed to UVB. Taken together, these data reveal that RhoA/ROCK signaling is one of the regulators contributing to oxidative damage and apoptosis in human keratinocytes, suggesting that RhoA/ROCK signaling has strong potential to be used as a useful therapeutic target in skin diseases including PV.

Indexed as

Oxidative StressSignal TransductionCell LineHumansKeratinocytesMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesNF-kappa BNod2 Signaling Adaptor ProteinPemphigusrhoA GTP-Binding Proteinrho-Associated KinasesUltraviolet RaysMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesNF-kappa BNOD2 protein, humanNod2 Signaling Adaptor ProteinrhoA GTP-Binding ProteinRHOA protein, humanrho-Associated KinasesApoptosisInflammatory responseOxidative stressPemphigus vulgaris (PV)RhoA/ROCK signaling

Identifiers

PMID28608226
OpenAlexW2624964143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.